Skip to main content

Albert Lecube Torelló

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Albert Lecube Torelló

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Papel de la Sex Hormone-Binding Globulin (SHBG) y de los esteroides sexuales en la distribución de la grasa corporal en la aparición de la diabetes mellitus tipo 2

IP: David Martinez Selva
Collaborators: Albert Lecube Torelló, Lorena Ramos Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI09/00144
Duration: 01/01/2010 - 31/12/2012

Sex hormone-binding globulin (SHBG): Identification of the molecular mechanisms that regulate its expression and role in body fat distribution and in the development of type 2 diabetes

IP: David Martinez Selva
Collaborators: Rafael Simó Canonge, Cristina Hernández Pascual, Albert Lecube Torelló
Funding agency: Instituto de Salud Carlos III
Funding: 42000
Reference: CP08/00058
Duration: 01/01/2009 - 31/12/2011

Mediadors patogènics de l'obesitat: Estudi comparatiu i exploració de nous candidats mitjançant l'anàlisi proteòmic del líquid cefalorraquidi

IP: Albert Lecube Torelló
Collaborators: Ma Antonia Poca Pastor
Funding agency: Societat Catalana d'Endocrinologia i Nutrició
Funding: 6000
Reference: SCEN_01_2007
Duration: 01/05/2008 - 30/04/2009

Síndrome de apneas-hipopneas del sueño en mujeres premenopáusicas con obesidad mórbida incluidas en un programa de cirugía bariátrica. Influencia sobre los factores de riesgo cardiovascular: activación simpática, inflamación y resistencia a la insulina

IP: Albert Lecube Torelló
Collaborators: Odile Romero Santo-Tomas, Jose Manuel Fort López-Barajas, Gabriel Sampol Rubio
Funding agency: Instituto de Salud Carlos III
Funding: 25410
Reference: PI060476
Duration: 01/01/2007 - 30/12/2009

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

Related professionals

Jorge Pamias Romero

Jorge Pamias Romero

Predoctoral researcher
New Technologies and Craniofacial Microsurgery
Read more
Olga Luengo Sanchez

Olga Luengo Sanchez

Senior researcher
Systemic Diseases
Read more
Pau Rello Sabaté

Pau Rello Sabaté

Predoctoral researcher
Cardiovascular Diseases
Read more
Mª Teresa Tórtola Fernández

Mª Teresa Tórtola Fernández

Senior researcher
Microbiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.